INCYTE CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.1 USD | -0.86% |
|
+4.67% | -9.36% |
| May. 13 | Equities Close Mixed as Markets Weigh Consumer Inflation Survey | MT |
| May. 13 | Equities Close Mixed as Markets Parse Consumer Inflation Survey | MT |
ETFs positioned on Incyte Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.55% | 254 M€ | +11.45% | - | |
| 2.94% | 1 M€ | -2.17% | - | |
| 2.88% | 0 M€ | 0.00% | - | |
| 2.10% | 4 M€ | +20.15% | ||
| 1.95% | 16 M€ | -3.37% | ||
| 1.68% | 0 M€ | 0.00% | - | |
| 1.65% | 2 M€ | +9.27% | ||
| 1.54% | 8 M€ | +4.88% | ||
| 1.50% | 0 M€ | 0.00% | - | |
| 0.41% | 13 M€ | -.--% | - | |
| 0.41% | 4 M€ | -.--% | - | |
| 0.41% | 3 M€ | +15.16% | - | |
| 0.37% | 17 M€ | +6.46% | - | |
| 0.29% | 104 M€ | +8.99% | ||
| 0.20% | 7 M€ | +5.61% | - | |
| 0.20% | 32 M€ | +1.38% | - | |
| 0.20% | 17 M€ | +5.61% | - | |
| 0.17% | 9 M€ | -.--% | - | |
| 0.17% | 375 M€ | +7.91% | ||
| 0.14% | 5 M€ | -72.95% | - | |
| 0.08% | 9 M€ | +9.07% | - | |
| 0.08% | 7 M€ | +0.11% | - | |
| 0.07% | 219 M€ | +17.17% | - | |
| 0.07% | 1,448 M€ | -.--% | - |
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows:
- product sales (85.6%);
- royalties (14.2%);
- income from research and cooperation agreements (0.2%).
Sector
Pharmaceuticals
Calendar
2024-05-15
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
57.6
USD
Average target price
73.35
USD
Spread / Average Target
+27.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.27% | 12.93B | |
| -2.47% | 89.37B | |
| +2.76% | 40.65B | |
| -12.92% | 32.81B | |
| +53.55% | 25B | |
| -16.51% | 15.29B | |
| -42.60% | 11.61B | |
| -12.82% | 11.49B | |
| +5.17% | 8.98B | |
| -7.72% | 8.23B |
- Stock Market
- Equities
- INCY Stock
- Funds and ETFs Incyte Corporation